I now have all the dosing data needed. Here is the complete, updated treatment guide with full drug doses and prescriptions integrated throughout:
π Comprehensive Acne Treatment Guide β With Full Drug Doses & Prescriptions
Sources: Dermatology 2-Volume Set 5e | Andrews' Diseases of the Skin 13e | Harriet Lane Handbook 23e | Katzung's Basic & Clinical Pharmacology 16e
Part I: Understanding Acne β Types & Classification
Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit driven by four pathogenic mechanisms:
- Follicular hyperkeratinization β comedone formation
- Sebaceous gland hyperactivity (androgen-driven excess sebum)
- Cutibacterium acnes colonization β inflammatory cascade
- Release of proinflammatory cytokines β papules, pustules, nodules, cysts
Lesion Types
| Lesion | Description |
|---|
| Open comedone (blackhead) | Dilated follicle open to surface; oxidized lipids = dark color |
| Closed comedone (whitehead) | Plugged follicle beneath skin |
| Papule | Small, raised, red inflammatory lesion < 5 mm |
| Pustule | Papule with visible purulent center |
| Nodule | Deep, solid, painful lesion β₯ 5 mm |
| Cyst/pseudocyst | Deep fluctuant lesion filled with pus/keratin |
Clinical Subtypes
| Type | Key Features |
|---|
| Comedonal acne | Predominantly open/closed comedones, minimal inflammation |
| Mild papulopustular | Scattered papules/pustules, few comedones |
| Moderate papulopustular | Multiple papules/pustules, few nodules |
| Nodular/cystic acne | Numerous deep nodules/cysts; high scar risk |
| Acne conglobata | Interconnected nodules, abscesses, sinus tracts; trunk; predominantly males |
| Acne fulminans | Sudden explosive nodular acne + systemic features (fever, arthralgia, leukocytosis) |
| Neonatal acne | Birthβ6 weeks; Malassezia-driven; self-limiting |
| Infantile acne | 2 monthsβ2 years; true comedonal/inflammatory |
| Acne mechanica | Friction/pressure-induced (helmets, straps) |
| Drug-induced acne | Corticosteroids, androgens, lithium, halogens, phenytoin |
| Hormonal acne (female) | Jawline/chin; perimenstrual flares; PCOS association |
Part II: Severity-Based Treatment Algorithm With Doses
π‘ MILD ACNE
Comedonal
Rx First-line:
Tretinoin 0.025% cream β apply a pea-sized amount to entire face at night; start every other night Γ 2 weeks β titrate to nightly as tolerated
Rx Alternative:
Adapalene 0.1% gel β apply nightly; may apply morning or evening (light-stable); available OTC
Rx Other alternatives:
Salicylic acid 0.5β2% wash or gel β apply once or twice daily (OTC)
Azelaic acid 15% gel β apply twice daily to affected area
Papulopustular Mild
Rx First-line combo:
Benzoyl peroxide (BPO) 2.5β5% gel/wash β apply once daily (morning), leave on β₯2 min if wash
+ Clindamycin 1% gel or lotion β apply twice daily (morning + night) to affected area
+ Tretinoin 0.025% cream or Adapalene 0.1% gel β apply nightly
Rx Fixed-combination products (improves adherence):
- Clindamycin 1.2% / BPO 2.5% gel (Duac/Benzaclin) β once daily
- Adapalene 0.1% / BPO 2.5% gel (Epiduo) β once daily
- Tretinoin 0.1% / Clindamycin 1.2% gel (Ziana) β once nightly
π MODERATE ACNE
Rx First-line:
Adapalene 0.3% gel or Tretinoin 0.05% cream β nightly to entire face
+ BPO 5% gel β once daily (morning)
+ Doxycycline 100 mg β orally twice daily with food and large glass of water Γ max 3 months
(Or: Doxycycline modified-release 40 mg once daily β equally efficacious, fewer photosensitivity/GI side effects)
Rx In women (hormonal option):
Spironolactone 50β100 mg/day β orally once daily; titrate to 100β200 mg/day as tolerated
+ Combined OCP (e.g., Drospirenone 3 mg / Ethinyl estradiol 0.02 mg [Yaz]) β one tablet daily Γ 21 days, 7 days off
Rx Alternative antibiotic for moderate:
Minocycline 50β100 mg β orally twice daily Γ max 3 months (use if doxycycline not tolerated)
Or Sarecycline 1.5 mg/kg/day (weight-based) β once daily orally
π΄ SEVERE ACNE (Nodular/Cystic)
Rx Drug of choice:
Isotretinoin 0.5β1 mg/kg/day β orally in 2 divided doses with fatty meal
Target cumulative dose: 120β150 mg/kg (reduces relapse risk)
Duration: typically 4β6 months (16β20 weeks)
Rx Bridge therapy (while starting isotretinoin):
Oral antibiotic (Doxycycline 100 mg twice daily) + Tretinoin 0.05β0.1% cream + BPO 5% gel
Rx Procedural:
Intralesional Triamcinolone acetonide 2.5β5 mg/mL β injected directly into nodule/cyst
(Dilute triamcinolone 40 mg/mL to desired concentration with normal saline; inject 0.05β0.1 mL per lesion)
Part III: Drug-by-Drug Prescribing Reference
π§΄ A. TOPICAL RETINOIDS β Full Formulary
All retinoids: Apply pea-sized amount to entire acne-prone region. Start every-other-night Γ 2 weeks β daily. Use SPF sunscreen daily. Avoid eyes and nasolabial folds.
| Drug | Vehicle | Strength | Pregnancy |
|---|
| Tretinoin | Cream | 0.025%, 0.05%, 0.1% | Category C |
| Gel | 0.01%, 0.025% | |
| Microsphere gel | 0.04%, 0.1% (less irritating) | |
| Polymerized cream/gel | 0.025% | |
| Adapalene | Gel | 0.1% (OTC), 0.3% (Rx) | Category C |
| Cream | 0.1% | |
| Lotion | 0.1% | |
| Tazarotene | Gel | 0.05%, 0.1% | Category X |
| Cream | 0.05%, 0.1% | |
Prescribing example:
Rx: Tretinoin 0.025% cream
Disp: 20 g tube
Sig: Apply a pea-sized amount to entire face at bedtime.
Start every other night Γ 2 weeks, then nightly.
Avoid eyes and corners of nose.
Use SPF 30+ sunscreen daily.
Refills: 5
π«§ B. BENZOYL PEROXIDE β Full Formulary
Available concentrations: 2.5%, 5%, 10% β gel, cream, foam, wash, lotion
No bacterial resistance develops. Always co-prescribe with antibiotics.
Standard dosing:
- Wash (2.5β5%): Apply to affected area, lather, leave 2 minutes, rinse. Once daily (morning).
- Leave-on gel/cream (2.5β5%): Apply thin layer once or twice daily.
- Start at 2.5% to minimize irritation; increase to 5β10% as tolerated.
Prescribing example:
Rx: Benzoyl Peroxide 5% gel (or wash)
Disp: 60 g tube
Sig: Apply once daily (morning) to affected areas.
If wash: leave in contact β₯2 minutes before rinsing.
Warning: Bleaches clothing, towels, bedding.
Refills: 3
π¦ C. TOPICAL ANTIBIOTICS β Full Formulary
Never monotherapy β always combine with BPO to prevent resistance.
| Drug | Formulation | Dose |
|---|
| Clindamycin 1% | Gel, lotion, solution, foam, pledgets | Apply twice daily (morning + evening) |
| Erythromycin 2% | Gel, solution | Apply twice daily; high resistance rates |
| Dapsone 5% gel | Gel | Apply twice daily; avoid applying BPO immediately after (skin discoloration) |
| Dapsone 7.5% gel | Gel | Apply once daily |
| Topical minocycline 4% foam | Foam | Apply once daily (newer agent) |
Prescribing example:
Rx: Clindamycin phosphate 1% gel
Disp: 30 g tube
Sig: Apply a thin layer to affected areas twice daily (AM + PM).
Use with benzoyl peroxide wash in the morning.
Refills: 2
π D. ORAL ANTIBIOTICS β Full Prescribing Details
Rule: Always combine with BPO Β± topical retinoid. Limit to 3 months maximum.
1. Doxycycline (First-line, preferred)
| Indication | Dose |
|---|
| Moderate acne | 100 mg orally twice daily with food |
| Sub-antimicrobial (anti-inflammatory, equal efficacy) | 40 mg modified-release (Oracea) once daily OR 20 mg twice daily |
| Severe acne | 100 mg twice daily initially; step down once controlled |
| Age restriction | β₯ 8 years only |
Side effects: Photosensitivity (use sunscreen), GI upset, esophagitis (take with full glass of water, remain upright β₯1 hour), vaginal candidiasis.
Rx: Doxycycline hyclate 100 mg tablets
Disp: 60 tablets (#60)
Sig: Take 1 tablet by mouth twice daily with food and
a full glass of water. Remain upright β₯1 hour.
Avoid prolonged sun exposure; use SPF 30+.
Duration: 3 months (do not use longer without review).
Refills: 0
2. Minocycline
| Form | Dose |
|---|
| Immediate release | 50β100 mg orally twice daily |
| Extended release (weight-based, preferred) | ~1 mg/kg/day once daily (45 mg for <60 kg; 90 mg for 60β90 kg; 135 mg for >90 kg) |
Side effects: Vestibular toxicity (dizziness/vertigo β common at onset), cutaneous/mucosal pigmentation, drug-induced lupus-like syndrome, drug hypersensitivity syndrome (within first 1β2 months), SJS (rare).
β οΈ More serious adverse events than doxycycline β many guidelines now prefer doxycycline as first-line.
Rx: Minocycline extended-release 90 mg tablets
Disp: 90 tablets
Sig: Take 1 tablet orally once daily with or without food.
Duration: 3 months maximum.
Warn: dizziness on first few doses; pigmentation changes.
Refills: 0
3. Sarecycline (Narrow-spectrum tetracycline, β₯9 years)
| Weight | Dose |
|---|
| 33β54 kg | 60 mg once daily |
| 55β84 kg | 100 mg once daily |
| 85β136 kg | 150 mg once daily |
Advantages: Narrow antimicrobial spectrum (less disruption of gut microbiome), fewer GI/photosensitivity side effects.
Rx: Sarecycline 100 mg tablet
Disp: 90 tablets
Sig: Take 1 tablet orally once daily with or without food.
Duration: 3 months.
Refills: 0
4. Erythromycin (Pregnancy/age <8 years)
| Indication | Dose |
|---|
| Moderate acne (β₯12 years) | 500 mg orally twice daily |
| Children <8 years | 30β50 mg/kg/day in divided doses |
| Infantile acne | 125β250 mg twice daily |
β οΈ High resistance rates worldwide β reserve for pregnancy or pediatric cases.
5. Azithromycin (Pregnancy/tetracycline intolerance)
| Dose schedule | Regimen |
|---|
| Pulse dosing | 500 mg orally once daily Γ 3 days per week for 4β12 weeks |
| Alternate | 250 mg once daily daily use |
6. Trimethoprim-Sulfamethoxazole (TMP-SMX)
- Dose: TMP 160 mg / SMX 800 mg (double-strength) β 1 tablet twice daily
- Use only for antibiotic-resistant cases or failed tetracyclines/macrolides
- Risk of severe adverse reactions (SJS, agranulocytosis) limits routine use
βοΈ E. ORAL ISOTRETINOIN β Complete Prescribing Guide
Indicated for: Severe nodular/cystic acne, acne with scarring, relapsing moderate acne, acne conglobata, acne fulminans (after steroids), severe acne resistant to antibiotics.
Dosing Protocol
| Phase | Dose | Notes |
|---|
| Starting dose | 0.5 mg/kg/day in 2 divided doses | Take with fatty meal (β absorption ~50%) |
| Titration (if tolerated) | 1 mg/kg/day in 2 divided doses | After 4β8 weeks if tolerating |
| Target cumulative dose | 120β150 mg/kg total | Associated with lowest relapse rate |
| Duration | 16β20 weeks (4β5 months) typical | Extend if cumulative dose not reached |
| Low-dose protocol (adults) | 0.25β0.5 mg/kg/day | Fewer side effects; longer course needed |
| Acne fulminans | Start 10β20 mg/day Γ 4 weeks (after 2β4 weeks of prednisolone) | Then titrate gradually |
Example for 70 kg patient:
Starting: 35 mg/day (0.5 mg/kg) Γ 4 weeks
Titrate: 70 mg/day (1 mg/kg) Γ remaining course
Target cumulative: 70 Γ 120 = 8,400 mg total
Pre-treatment Workup (Before Starting)
| Test | Timing |
|---|
| Pregnancy test (females) | Baseline, monthly |
| Fasting lipid panel | Baseline, at 4 weeks, 8 weeks |
| LFTs (AST, ALT) | Baseline, 4 weeks, 8 weeks |
| CBC | Baseline |
| Depression screening | Baseline and each visit |
Side Effect Management
| Side Effect | Management |
|---|
| Cheilitis (universal) | Petroleum jelly/lip balm multiple times daily |
| Dry skin/eczema | Non-comedogenic moisturizer; gentle cleanser |
| Dry eyes | Artificial tears; avoid contact lenses if severe |
| Nosebleeds | Nasal saline; petroleum jelly in nostrils |
| Hypertriglyceridemia | Dietary fat restriction; reduce dose; add fenofibrate if TG >500 mg/dL |
| LFT elevation | Reduce dose; stop if >3Γ ULN |
| Musculoskeletal pain | NSAIDs; reduce dose |
| Teratogenicity | 2 forms contraception + monthly pregnancy test (iPLEDGE) |
| Pseudotumor cerebri | Never combine with tetracyclines |
Contraindications: Pregnancy (absolute), breastfeeding, severe hyperlipidemia, hepatic failure.
Rx: Isotretinoin (Accutane/generic) 20 mg soft gelatin capsules
Disp: 60 capsules
Sig: Take 1 capsule (20 mg) twice daily with meals
(start 0.5 mg/kg/day; titrate to 1 mg/kg/day).
Target total dose: 120β150 mg/kg.
Enrolled in iPLEDGE program.
No pregnancy β two forms contraception required.
Labs at weeks 4 and 8 (lipids, LFTs, CBC).
Refills: Per iPLEDGE (monthly Rx only)
π©Ί F. HORMONAL THERAPY β Full Prescribing
1. Spironolactone (Women only)
| Phase | Dose |
|---|
| Starting | 50 mg orally once daily |
| Maintenance | 100 mg/day (most effective dose) |
| Maximum | 200 mg/day (split into twice daily) |
| Duration | 3β6 months for initial response; can use long-term |
Monitoring: Serum potassium (baseline, 1 month, then periodically); BP; menstrual cycle regularity.
Side effects: Menstrual irregularity (co-prescribe OCP), breast tenderness, polyuria, dizziness, hyperkalemia.
Rx: Spironolactone 100 mg tablets
Disp: 90 tablets
Sig: Take 1 tablet orally once daily.
Monitor potassium at 1 month.
Use reliable contraception (teratogenic).
Avoid in pregnancy and with ACE-I/ARB.
Refills: 2
2. Combined Oral Contraceptives (FDA-approved for acne)
| Brand | Composition | Dose |
|---|
| Yaz (most anti-androgenic) | Drospirenone 3 mg + EE 0.02 mg | 1 tablet daily Γ 21 days, 7-day break |
| Ortho Tri-Cyclen | Norgestimate + EE (triphasic) | 1 tablet daily Γ 28 days |
| Estrostep Fe | Norethindrone + EE (triphasic) | 1 tablet daily Γ 28 days |
Onset of acne benefit: 3β6 menstrual cycles. Meta-analysis shows equivalence to oral antibiotics at 6 months for inflammatory acne.
Contraindications: Smokers >35 years, history of VTE/stroke, migraine with aura, hormone-sensitive cancer.
Rx: Drospirenone 3 mg / Ethinyl Estradiol 0.020 mg (Yaz)
Disp: 1 blister pack (28 tablets)
Sig: Take 1 tablet daily at same time; follow pack sequence
(24 active + 4 inert tablets).
Refills: 11
π¬ G. OTHER TOPICAL AGENTS WITH DOSES
| Drug | Concentration | Dose | Notes |
|---|
| Azelaic acid | 15% gel (Finacea) / 20% cream (Azelex) | Apply twice daily to affected area | Lightens PIH; safe in pregnancy (Cat B) |
| Salicylic acid | 0.5β2% wash, gel, pads | Apply once or twice daily | OTC; comedolytic |
| Clascoterone | 1% cream (Winlevi) | Apply twice daily to affected area | Topical androgen receptor blocker; β₯12 years |
| Niacinamide | 2% gel | Apply twice daily | Non-inferior to clindamycin 1% for moderate acne |
| Sodium sulfacetamide 10% / Sulfur 5% | Cream, lotion, wash | Apply once or twice daily | Mild; also useful in rosacea |
Prescribing example (azelaic acid):
Rx: Azelaic acid 15% gel (Finacea)
Disp: 30 g tube
Sig: Apply a thin layer to affected areas twice daily
(morning and evening) after washing face.
Safe in pregnancy. May sting initially.
Refills: 3
Part IV: Special Acne Variants β Specific Doses
π΄ Acne Conglobata β Treatment
- Oral isotretinoin 1 mg/kg/day in 2 divided doses; cumulative 150 mg/kg
- Bridge: Doxycycline 100 mg twice daily + topical retinoid + BPO (while isotretinoin takes effect)
- Intralesional triamcinolone 5 mg/mL into individual nodules
- Surgical: I&D of fluctuant abscesses
- Refractory: Oral dapsone 50β100 mg/day; adalimumab (biologic β off-label)
π₯ Acne Fulminans β Stepwise Protocol
β οΈ Do NOT start high-dose isotretinoin acutely β risk of paradoxical worsening.
| Step | Drug | Dose & Duration |
|---|
| Step 1 | Prednisolone | 0.5β1 mg/kg/day orally Γ 2β4 weeks; then taper over 4β8 weeks |
| Step 2 | Isotretinoin (low start) | 10β20 mg/day (start Week 2β4 of steroids) |
| Step 3 | Titrate isotretinoin | Increase to 0.5 mg/kg/day β 1 mg/kg/day while tapering steroids |
| Adjunct | Naproxen or Ibuprofen | 400β600 mg 3Γ/day for arthralgia and fever |
| Topical | BPO 5% + topical retinoid | As adjuncts throughout |
πΆ Neonatal & Infantile Acne β Dosing
Neonatal (0β6 weeks):
Rx: Ketoconazole 2% cream
Sig: Apply to affected area twice daily Γ 4β6 weeks
(if Malassezia-driven neonatal cephalic pustulosis confirmed)
Infantile (2 monthsβ2 years):
- Mild: Adapalene 0.1% gel β apply every other night; BPO 2.5% wash
- Moderate: Erythromycin ethylsuccinate 30β50 mg/kg/day in 3β4 divided doses orally Γ 6β8 weeks
- Rule out androgen excess (measure testosterone, DHEAS, 17-OH progesterone)
π© Hormonal/Adult Female Acne β Prescription Summary
First-choice:
Rx: Spironolactone 100 mg daily + Yaz 1 tablet daily
+ Adapalene 0.3% gel nightly + BPO 5% wash AM
Second-choice if OCP contraindicated:
Rx: Spironolactone 100β200 mg daily alone
(with reliable non-hormonal contraception)
π Drug-Induced Acne
- Discontinue offending drug when possible
- Corticosteroid-induced (monomorphic pustular): BPO 5% gel once daily; Doxycycline 100 mg twice daily if widespread
- EGFR inhibitor acne: Topical clindamycin 1% + topical steroid (mild); doxycycline 100 mg twice daily (moderateβsevere)
π€° Pregnancy-Safe Acne Treatment β Prescriptions
| Drug | Pregnancy Category | Dose |
|---|
| Azelaic acid 15β20% | B | Twice daily topically |
| Topical clindamycin 1% | B | Twice daily topically |
| Topical erythromycin 2% | B | Twice daily topically |
| BPO 2.5β5% | C (limited use) | Once daily wash |
| Azithromycin 500 mg | B | 500 mg 3Γ/week pulse Γ 6β8 weeks |
| Cephalexin 500 mg | B | 250β500 mg twice daily Γ 3β4 months |
| Intralesional triamcinolone 2.5β5 mg/mL | (consult OB) | Per nodule; office procedure |
β Absolutely contraindicated in pregnancy: Isotretinoin, all tetracyclines, tazarotene, spironolactone.
Part V: Procedural Treatments With Doses
| Procedure | Drug/Device | Dose/Technique |
|---|
| Intralesional steroid | Triamcinolone acetonide 2.5β5 mg/mL | 0.05β0.1 mL per lesion; dilute 40 mg/mL stock with NS |
| Chemical peel | Salicylic acid 20β30%; Glycolic acid 30β70% | Applied by dermatologist; 2β4 sessions q3β4 weeks |
| PDT | Aminolevulinic acid 20% + red/blue light | Applied 30β60 min before light activation; 2β4 sessions |
| Blue light | 415 nm | 8β10 min sessions, 2Γ weekly Γ 4β8 weeks |
| Fractional COβ laser | 10,600 nm | For acne scarring; 3β5 sessions q4β8 weeks |
| Subcision | 18-gauge needle or Nokor needle | Breaks fibrous scar bands; for rolling scars |
Part VI: Maintenance Therapy
After achieving control, switch to maintenance to prevent relapse:
Maintenance Rx (standard):
Adapalene 0.1% gel β apply nightly to entire face
Β± BPO 2.5% wash β once daily (especially if was on antibiotics)
Duration: Indefinite (months to years as needed)
Topical retinoids alone are the gold standard maintenance β they prevent new comedone formation and address subclinical microcomedones.
Part VII: Summary Prescribing Reference by Severity
| Severity | Typical Prescription Combination |
|---|
| Mild comedonal | Tretinoin 0.025% cream nightly |
| Mild papulopustular | BPO 5% wash (AM) + Clindamycin 1% gel (PM) + Adapalene 0.1% gel (night) |
| Moderate | Doxycycline 100 mg BID Γ 3 months + Adapalene 0.3% nightly + BPO 5% wash daily |
| Moderate (female) | Spironolactone 100 mg daily + Yaz + Adapalene 0.3% nightly |
| Severe nodular | Isotretinoin 0.5 β 1 mg/kg/day; cumulative 120β150 mg/kg |
| Acne conglobata | Isotretinoin 1 mg/kg/day + intralesional triamcinolone |
| Acne fulminans | Prednisolone 0.5β1 mg/kg/day β Isotretinoin 10 mg/day β titrate |
| Neonatal | Ketoconazole 2% cream BID (if needed) |
| Infantile moderate | Erythromycin 30β50 mg/kg/day in divided doses |
| Pregnant | Topical clindamycin 1% + Azelaic acid 15% BID |
| Maintenance | Adapalene 0.1% gel nightly Β± BPO 2.5% wash |
Sources: Dermatology 2-Volume Set 5e, pp. 728β729 | Andrews' Diseases of the Skin 13e, pp. 280β283 | Harriet Lane Handbook 23e, pp. 282β285 | Katzung's Basic & Clinical Pharmacology 16e
β οΈ Clinical Disclaimer: All prescriptions should be individualized based on patient age, weight, comorbidities, contraindications, and local antibiotic resistance patterns. Isotretinoin requires enrollment in the iPLEDGE REMS program in the USA.